INTRODUCTION:Laparoscopic Nissen fundoplication offers significant improvement in gastroesophageal reflux disease (GERD) symptom severity and frequency. This study was undertaken to determine the impact of preoperative medical comorbidities on the outcome and satisfaction of patients undergoing fundoplication for GERD. METHODS: Prior to fundoplication, patients underwent esophageal motility testing and 24-h pH monitoring. Before and after fundoplication, the frequency and severity of reflux symptoms were scored using a Likert scale. Medical comorbidities were classified by organ systems, and patients were assigned points corresponding to the number of medical comorbidities they had. In addition, all patients were assigned Charlson comorbidity index (CCI) scores according to the medical comorbidities they had. A medical comorbidity was defined as a preexisting medical condition, not related to GERD, for which the patient was receiving treatment. Analyses were then conducted to determine the impact of medical comorbidities as well as CCI score on overall outcome, symptom improvement, and satisfaction. RESULTS:Six hundred and ninety-six patients underwent fundoplication: 538 patients had no medical comorbidities and 158 patients had one or more medical comorbidities. Preoperatively, there were no differences in symptom severity and frequency scores between patients with or without medical comorbidities. Postoperatively, all patients had improvement in their symptom severity and frequency scores. There were no differences in postoperative symptom scores between the patients with medical comorbidities and those without. The majority of patients were satisfied with their overall outcome; there was no relationship between the number of medical comorbidities and satisfaction scores. These findings were mirrored when patients' CCI scores were compared with satisfaction, overall outcome, and symptom improvement. CONCLUSION: These results promote further application of laparoscopic Nissen fundoplication, even for patients with medical comorbidities.
RCT Entities:
INTRODUCTION: Laparoscopic Nissen fundoplication offers significant improvement in gastroesophageal reflux disease (GERD) symptom severity and frequency. This study was undertaken to determine the impact of preoperative medical comorbidities on the outcome and satisfaction of patients undergoing fundoplication for GERD. METHODS: Prior to fundoplication, patients underwent esophageal motility testing and 24-h pH monitoring. Before and after fundoplication, the frequency and severity of reflux symptoms were scored using a Likert scale. Medical comorbidities were classified by organ systems, and patients were assigned points corresponding to the number of medical comorbidities they had. In addition, all patients were assigned Charlson comorbidity index (CCI) scores according to the medical comorbidities they had. A medical comorbidity was defined as a preexisting medical condition, not related to GERD, for which the patient was receiving treatment. Analyses were then conducted to determine the impact of medical comorbidities as well as CCI score on overall outcome, symptom improvement, and satisfaction. RESULTS: Six hundred and ninety-six patients underwent fundoplication: 538 patients had no medical comorbidities and 158 patients had one or more medical comorbidities. Preoperatively, there were no differences in symptom severity and frequency scores between patients with or without medical comorbidities. Postoperatively, all patients had improvement in their symptom severity and frequency scores. There were no differences in postoperative symptom scores between the patients with medical comorbidities and those without. The majority of patients were satisfied with their overall outcome; there was no relationship between the number of medical comorbidities and satisfaction scores. These findings were mirrored when patients' CCI scores were compared with satisfaction, overall outcome, and symptom improvement. CONCLUSION: These results promote further application of laparoscopic Nissen fundoplication, even for patients with medical comorbidities.
Authors: Sharona B Ross; Desiree Villadolid; Harold Paul; Sam Al-Saadi; Javier Gonzalez; Sarah M Cowgill; Alexander Rosemurgy Journal: Am Surg Date: 2008-07 Impact factor: 0.688
Authors: T J Heikkinen; K Haukipuro; P Koivukangas; A Sorasto; R Autio; H Södervik; H Mäkelä; A Hulkko Journal: J Am Coll Surg Date: 1999-04 Impact factor: 6.113
Authors: Sarah M Cowgill; Dean Arnaoutakis; Desiree Villadolid; Sam Al-Saadi; Demetri Arnaoutakis; Daniel L Molloy; Ashley Thomas; Steven Rakita; Alexander Rosemurgy Journal: Am Surg Date: 2006-09 Impact factor: 0.688
Authors: Matthew J D'Alessio; Steven Rakita; Mark Bloomston; Christopher M Chambers; Emmanuel E Zervos; Steven B Goldin; Jerry Poklepovic; H Worth Boyce; Alexander S Rosemurgy Journal: J Am Coll Surg Date: 2005-09 Impact factor: 6.113
Authors: Marco G Patti; Warren J Gasper; Piero M Fisichella; Ian Nipomnick; Francesco Palazzo Journal: J Gastrointest Surg Date: 2008-09-03 Impact factor: 3.452
Authors: Sarah M Cowgill; Mark Bloomston; Sam Al-Saadi; Desiree Villadolid; Alexander S Rosemurgy Journal: J Gastrointest Surg Date: 2007-06 Impact factor: 3.267
Authors: Leigh A Humphries; Jonathan M Hernandez; Whalen Clark; Kenneth Luberice; Sharona B Ross; Alexander S Rosemurgy Journal: Surg Endosc Date: 2013-03-19 Impact factor: 4.584